BridgeBio Pharma Inc. – Filings and Transcripts

NASDAQ: BBIO
Share price (4/6/26): $72.28
Market cap (4/6/26): $14.0 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Viking Global Investors LP

Vanguard Group Inc

Trimarchi Thomas

News Filter

Submits NDA to FDA for BBP-418 for Individuals Living With LGMD2I/R9

Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates

Reports Positive Phase 3 Topline Results for Oral Infigratinib With the First Statistically Significant Improvements in Body Proportionality in Achondroplasia

Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes Due 2033 to Prefund Repayment of Convertible Senior Notes Due 2027

Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Scanned paper annual report submission

Notice of effectiveness